key: cord-0870683-gu989xt6
authors: Gandhi, Jagdeep Singh
title: Comment on: Conventional immunosuppression: the search for scientific evidence
date: 2020-12-08
journal: Eye (Lond)
DOI: 10.1038/s41433-020-01343-7
sha: 75f6d10d4ffc8f15384f9ec9811d8804d17b2872
doc_id: 870683
cord_uid: gu989xt6

nan

Various local and systemic suppressants of inflammation are found in uveitis care. Biologics were 10% of the drugs in one report from Germany [2] . Local steroid usage was also conspicuous. Intravitreal steroid is now mainstream, but its uncostly forerunner-periocular steroid-retains a niche. Recently, in the Covid-19 bedlam, after due consent, for uveitis patients I have used subconjunctival Triamcinolone.

On the slit-lamp, a depot is injected at the inferior fornix: in Britain a common option is 20 mg of Triamcinolone (e.g. Kenalog with alcohol vehicle removed). Marked vitreous haze and cells are thereby cleared. Cataract and ocular hypertension may occur, and are dealt with as necessary. Rare adversities can emerge [3] . But such steroid, if bothersome, is readily excisable from the conjunctiva. Also, unlike the posterior subtenon route, the subconjunctival route carries the boon of great repeatability.

Because intravitreal implants are high-priced it is fitting that cheaper care is being sought. Hence work has begun to compare Dexamethasone implant with subconjunctival Triamcinolone [4] . Dexa implant is priced at £1000 and Kenacort at only £3. If the conjunctival depot has a therapeutic potency that is akin to the implant then the monetary savings will be gargantuan. For uveitis I have found conjunctival steroid to be mightily effectual.

In many clinics a patient can access high-cost drugs, but in many more clinics a patient cannot. While staying upto-date, we should not reject the therapeutic legitimacy of earlier drugs and methods. Evidently, there is scope for the honing of older strategies as the rate of clinic growth outstrips available funds.

Conflict of interest The author declares that he has no conflict of interest.

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

* Jagdeep Singh Gandhi doctorjsg@gmail.com

Conventional immunosuppression: the search for scientific evidence

Intermediate uveitis: pattern of aetiology, complications, treatment and outcome in a tertiary academic centre

Conjunctival ulceration following triamcinolone injection

Comparison of two techniques used in routine care for the treatment of inflammatory macular oedema, subconjunctival triamcinolone and intravitreal dexamethasone implant: medical and economic importance of this randomised controlled trial